دوره 11، شماره 3 - ( 3-1399 )                   جلد 11 شماره 3 صفحات 314-310 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faramarzi E, Jaberi N, Farahbakhsh M, Ostadrahimi A, Asghari Jafarabadi M, Fakhari A. Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication. Caspian J Intern Med 2020; 11 (3) :310-314
URL: http://caspjim.com/article-1-2035-fa.html
Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication. . 1399; 11 (3) :310-314

URL: http://caspjim.com/article-1-2035-fa.html


چکیده:   (3891 مشاهده)
Background: This study was conducted to determine the prevalence of metabolic syndrome (Mets) in schizophrenic patients in a 6-month period of treatment with antipsychotic medications.
Methods: In this study, 60 volunteer schizophrenic patients were included. At the onset and 6 months after treatment with antipsychotic medications, fasting blood sugar (FBS), serum triglyceride (TG), high density lipoprotein (HDL), weight, waist circumference (WC), and blood pressure were determined. We defined Mets according to ATPIII criteria.
Results: After a 6-month treatment with antipsychotic drugs, the mean WC, serum TG, HDL, systolic and diastolic blood pressure increased but the changes of WC and HDL were statistically significant (p<0.05). We found that the percentage of patients with high WC, low HDL levels, and Mets increased after treatment which was statistically significant (p<0.05).
Conclusion: It is recommended that nutritional and lifestyle changes intervention should be implanted for schizophrenic patients undergoing treatment.
متن کامل [PDF 200 kb]   (1083 دریافت)    
نوع مطالعه: Original Article | موضوع مقاله: psychiatry
دریافت: 1398/6/5 | پذیرش: 1398/11/14 | انتشار: 1399/3/1

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 CC BY-NC 4.0 | Caspian Journal of Internal Medicine

Designed & Developed by : Yektaweb